Literature DB >> 23237902

Neuroendocrine considerations in the treatment of men and women with epilepsy.

Cynthia L Harden1, Page B Pennell.   

Abstract

Complex, multidirectional interactions between hormones, seizures, and the medications used to control them can present a challenge for clinicians treating patients with epilepsy. Many hormones act as neurosteroids, modulating brain excitability via direct binding sites. Thus, changes in endogenous or exogenous hormone levels can affect the occurrence of seizures directly as well as indirectly through pharmacokinetic effects that alter the concentrations of antiepileptic drugs. The underlying structural and physiological brain abnormalities of epilepsy and the metabolic activity of antiepileptic drugs can adversely affect hypothalamic and gonadal functioning. Knowledge of these complex interactions has increased and can now be incorporated in meaningful treatment approaches for men and women with epilepsy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23237902      PMCID: PMC4928713          DOI: 10.1016/S1474-4422(12)70239-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  107 in total

1.  Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.

Authors:  A G Herzog; K M Fowler; S D Smithson; L A Kalayjian; C N Heck; M R Sperling; J D Liporace; C L Harden; B A Dworetzky; P B Pennell; J M Massaro
Journal:  Neurology       Date:  2012-05-30       Impact factor: 9.910

2.  Effect of lamotrigine on sexual function in patients with epilepsy.

Authors:  A Gil-Nagel; F López-Muñoz; J M Serratosa; I Moncada; P García-García; C Alamo
Journal:  Seizure       Date:  2006-01-24       Impact factor: 3.184

Review 3.  Update on medications with adverse skeletal effects.

Authors:  Caroline J Davidge Pitts; Ann E Kearns
Journal:  Mayo Clin Proc       Date:  2011-03-09       Impact factor: 7.616

Review 4.  Neuroendocrinological aspects of epilepsy: important issues and trends in future research.

Authors:  Alison M Pack; Doodipala Samba Reddy; Susan Duncan; Andrew Herzog
Journal:  Epilepsy Behav       Date:  2011-03-30       Impact factor: 2.937

5.  Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat.

Authors:  M Gulinello; Q H Gong; X Li; S S Smith
Journal:  Brain Res       Date:  2001-08-10       Impact factor: 3.252

6.  Sexual dysfunction in partial epilepsy: a deficit in physiologic sexual arousal.

Authors:  M J Morrell; M R Sperling; M Stecker; M A Dichter
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

7.  The current evaluation and treatment of infantile spasms among members of the Child Neurology Society.

Authors:  John R Mytinger; Sucheta Joshi
Journal:  J Child Neurol       Date:  2012-08-21       Impact factor: 1.987

8.  Hormone binding globulins and anticonvulsant therapy.

Authors:  G H Beastall; R A Cowan; J M Gray; I Fogelman
Journal:  Scott Med J       Date:  1985-04       Impact factor: 0.729

Review 9.  Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits.

Authors:  Sheryl S Smith; Hui Shen; Qi Hua Gong; Xiangping Zhou
Journal:  Pharmacol Ther       Date:  2007-04-21       Impact factor: 12.310

10.  Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.

Authors:  Linda J Stephen; Graeme J Sills; John Paul Leach; Elaine Butler; Pamela Parker; Nikolas Hitiris; Veronica M Leach; Elaine A Wilson; Martin J Brodie
Journal:  Epilepsy Res       Date:  2007-06-05       Impact factor: 3.045

View more
  23 in total

1.  Having Catamenial Epilepsy Equals Fewer Seizures in Pregnancy.

Authors:  Alison M Pack
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

2.  Levetiracetam in Men With Epilepsy: Testosterone Is Left Alone But Sperm Count Is Paramount.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2017 Mar-Apr       Impact factor: 7.500

3.  2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan.

Authors:  Alica M Goldman; W Curt LaFrance; Tim Benke; Miya Asato; Dan Drane; Alison Pack; Tanvir Syed; Robert Doss; Samden Lhatoo; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

4.  Women with epilepsy.

Authors:  A Sharma; F Boller; M Koubeissi
Journal:  Funct Neurol       Date:  2016 Jul-Sep

5.  Metabolome-wide association study of anti-epileptic drug treatment during pregnancy.

Authors:  Douglas I Walker; Kayla Perry-Walker; Richard H Finnell; Kurt D Pennell; Vilinh Tran; Ryan C May; Thomas F McElrath; Kimford J Meador; Page B Pennell; Dean P Jones
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-04       Impact factor: 4.219

6.  Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry.

Authors:  Kurt D Pennell; Mark A Woodin; Page B Pennell
Journal:  Steroids       Date:  2014-12-23       Impact factor: 2.668

7.  Anti-mullerian hormone is higher in seizure-free women with epilepsy compared to those with ongoing seizures.

Authors:  Cynthia L Harden; Page B Pennell; Jacqueline A French; Anne Davis; Connie Lau; Nichelle Llewellyn; Benjamin Kaufman; Emilia Bagiella; Ariel Kirshenbaum
Journal:  Epilepsy Res       Date:  2016-08-17       Impact factor: 3.045

Review 8.  Women with epilepsy: clinically relevant issues.

Authors:  S Bangar; Abhishek Shastri; Hany El-Sayeh; Andrea E Cavanna
Journal:  Funct Neurol       Date:  2016 Jul-Sep

Review 9.  A Treatment Approach to Catamenial Epilepsy.

Authors:  Allison Navis; Cynthia Harden
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

Review 10.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.